Hyderabad-based drug maker Aurobindo Pharmaceuticals said in a filing with the Bombay Stock Exchange that has received temporary approval for Tenofovir Disoproxil Fumarate tablets, 300 mg from the US Food and Drug Administration.
A Tenofovir Disoproxil Fumarate tablet, 300 mg is the generic equivalent of Gilead Science Inc's Viread Tablets 300mg and falls under the anti-retroviral segment.
It is indicated in combination with other anti-retroviral for the treatment of HIV-1 infection in adults. Aurobindo has obtained a license from Gilead to market Tenofovir products in 95 developing and least developed countries.
Aurobindo now has a total of 91 abbreviated new drug application (ANDA) approvals from USFDA. Sixty-six of these are final and 25 are tentative, the filing said.
Add this page to your favorite Social Bookmarking websites
Hyderabad-based drug maker Aurobindo Pharmaceuticals said in a filing with the Bombay Stock Exchange that has received temporary approval for Tenofovir Disoproxil Fumarate tablets, 300 mg from the US Food and Drug Administration.
